DANIEL KRAFT
AI in Healthcare | Future of Medicine | Longevity & Healthspan
Dr Daniel Kraft is a Stanford- and Harvard-trained physician-scientist, inventor and investor focused on how AI and exponential technologies are reshaping health, medicine and the delivery of care. He is Founder and Chair of NextMed Health, Founder of Digital.Health, Co-Founder and General Partner at Continuum Health Ventures, and Adjunct Professor of Medicine at Stanford University School of Medicine. Board certified in internal medicine and paediatrics, with fellowship training in haematology, oncology and bone marrow transplantation at Stanford, he invented the FDA-cleared MarrowMiner and holds patents in medical devices, immunology and stem cell therapies. A six-time TED and TEDMED speaker whose work has featured on CNN, in WIRED and in National Geographic, he is an Aspen Institute Health Innovators Fellow, an active pilot and a former NASA astronaut finalist.
Speaking Topics
Dr Daniel Kraft explores how AI and other converging, often exponential technologies are reshaping health and medicine, and what those changes mean for the people delivering, funding and experiencing care. His customised keynotes and executive sessions use his Now, Near and Next framework to connect future possibilities with practical decisions for healthcare leaders, businesses and investors.
Every engagement is tailored to the audience and event. Topics can be combined or adapted for keynotes, fireside conversations, moderated panels, workshops and closed-door executive sessions.
Health and Medicine in the Age of AI: What’s Now, Near and Next
Signature keynote · For healthcare, business and investor audiences
What happens when healthcare becomes predictive, personalised and connected? In his high-energy, highly visual signature keynote, Dr Daniel Kraft takes audiences on a fast-paced tour of accelerating technologies, from foundation models and agentic AI to wearables, multi-omics, robotics and synthetic biology, and shows why the biggest shifts happen where they converge. His Now, Near and Next framework separates what is ready today from what is coming. Audiences leave inspired about what is possible and clear on what they can do about it, starting now.
AI in Healthcare: From Pilots to Practice
For clinical, health system, biopharma, payer and healthcare technology audiences
Where is AI actually delivering value in healthcare, and where do the claims outrun the capability? Dr Daniel Kraft offers a grounded look at generative, multimodal and agentic AI across clinical documentation, decision support, diagnostics, patient engagement and enterprise operations. He explains what separates real deployment from pilots that never scale: usable data, clinical validation, workflow integration, governance and a payment model that works. Audiences leave knowing which applications to back first and how to prepare their teams.
AI and the Future of Biopharma: From Discovery to the Patient
For biopharma leadership, R&D, commercial, medical affairs and market access teams
Dr Daniel Kraft examines where AI is changing the economics of discovery and development, from target identification and molecular design to trial design, synthetic control arms and regulatory submission. He treats the digitally enabled patient journey as one connected layer: shortening time to diagnosis, finding patients upstream, and understanding adherence and response. He also explores what changes for commercial, medical affairs and market access teams. Leadership teams come away with a clear read on their own data position and the validation bar their AI claims should meet.
Investing in the Future of Health: What’s Next and What Will Scale
For investor groups, financial services firms, private equity, venture capital and family offices
Scientific progress creates possibilities; adoption decides which become durable businesses. Dr Daniel Kraft, physician-scientist, Kauffman Fellow and General Partner at Continuum Health Ventures, examines how AI, advanced diagnostics, longevity and new models of care are rewriting business models across healthcare delivery, biopharma and consumer health. Using his Now, Near and Next framework, he shows how reimbursement, workflow fit and data advantage decide which companies actually get there. Investors leave with a sharper line between technical promise and commercial readiness.
From Sick Care to Health Care: The Future of Longevity and Healthspan
For consumer health, wellness, employer, payer and longevity-focused audiences
How can we help people stay healthier for longer? Dr Daniel Kraft, a physician and stem cell biologist, explores the shift from treating illness after it appears towards proactive, personalised health, with consumers reshaping prevention and monitoring without waiting for permission from the system. He examines what the evidence supports across metabolic health, sleep and continuous monitoring, and what it does not. Audiences leave able to separate established practice from experimental approaches and commercial claims.
Stage Zero: Earlier Detection and the Future of Prevention
For diagnostics, laboratory, imaging, pathology and life sciences audiences
What if we could detect disease at stage zero? Dr Daniel Kraft explores how wearables, digital biomarkers, at-home testing and low-cost personal omics reveal what happens between clinical visits, alongside liquid biopsy, multi-cancer early detection, computational pathology and AI-assisted imaging. He examines what it means when the lab moves from the end of the workup to the front of prediction. Audiences leave with a practical test for any new diagnostic: does better detection lead to measurable patient benefit?
From Hospital to Home: Care Without Walls
For health systems, provider organisations and care delivery audiences
As more care moves beyond the hospital and clinic, the challenge is redesigning how it is delivered. Dr Daniel Kraft examines remote monitoring, digital health, home diagnostics, virtual care and hospital-at-home, including the operational reasons promising programmes stall before they scale. He explores the evolving clinician role, from the virtualist to AI-augmented teams, and what the hospital becomes as a result. Health system leaders leave with a clear view of what it takes to deliver more care safely at home.
Leading Through Exponential Change
Closed-door strategy session for boards and executive leadership teams
Dr Daniel Kraft leads a facilitated, closed-door discussion of where AI, digital health and emerging medicine touch an organisation’s specific strategy, set against what competitors are actually doing. Drawing on his role as founding faculty and chair of medicine at Singularity University, and more than a decade leading Exponential Medicine (now NextMed Health), he applies exponential thinking and his Now, Near and Next framework to help leaders decide where to act, what to test and what to monitor, starting with the data question. Available as a two-to-three-hour session or within a longer agreed agenda, with a written summary of agreed priorities. Recent sessions include the boards of Argenx and Atrium Health and the executive leadership teams of Teva and Roche.
What Audiences Say
“Bravo to you for one of the best healthcare talks I have heard in the 23 years I have worked in this field.”
“Your presentation was fascinating and achieved the highest presenter engagement score across the board in all three markets.”
“My mind was blown! I am so excited and motivated to learn how I can use AI to upscale the way I deliver care to my patients.”
Recent Engagements
Eli Lilly · Gilead · Aetna · UBS · Apollo Global Management · J.P. Morgan Healthcare Conference (with Philips) · WHX Health Leaders, Dubai · ICT&health World Conference, Maastricht · AMGA · MEDICA · DLD Munich · CogX Festival, The O2, London
Organisations Served
Roche · Teva · Argenx · Sanofi · AstraZeneca · Genentech · Novartis · Philips · Abbott · Boston Scientific · Stryker · BUPA · AIA · Anthem · Atrium Health · EY · Deloitte · YPO · TIGER 21
As Featured In
National Geographic · CNN · WIRED · WIRED Japan · NewsNation · Medscape · NPR (TechNation Health)
Interested in booking Dr Daniel Kraft? Daniel is happy to speak with your team ahead of booking to shape the right topic and format.
CONTACT ORATION FOR MORE INFORMATION
BIOGRAPHY
Dr Daniel Kraft is a Stanford- and Harvard-trained physician-scientist, inventor and investor who has spent more than 25 years at the intersection of clinical medicine, biomedical research and emerging technology. His work explores how artificial intelligence, continuous data and converging technologies are reshaping prevention, diagnosis, therapy and the delivery of care. Through his Now, Near and Next framework, he shows leaders, clinicians and patients what they can do about it now, rather than someday.
He is Founder and Chair of NextMed Health (which began as Exponential Medicine at Singularity University), a programme and community bringing together clinicians, technologists, investors and regulators around the future of medicine, and Founder of Digital.Health, a curated platform for discovering and evaluating digital health and AI solutions. He is Co-Founder and General Partner at Continuum Health Ventures, backing early-stage companies working to democratise health and extend healthspan, and serves as Adjunct Professor of Medicine at Stanford University School of Medicine. He sits on the boards of Healthy.io and Immunis Biomedical, was founding faculty at Singularity University, where he chaired its medicine programme, and served as chair of the XPRIZE Pandemic & Health Alliance.
After undergraduate studies at Brown University and medical school at Stanford, Daniel was board certified in both internal medicine and paediatrics following a Harvard residency at Massachusetts General Hospital and Boston Children’s Hospital. He completed fellowships in haematology, oncology and bone marrow transplantation at Stanford. His laboratory research in stem cell biology, cancer immunotherapy and bioengineered T-cell differentiation has been published in Nature and Science. He founded RegenMed Systems, invented its FDA-cleared MarrowMiner, a device for minimally invasive bone marrow harvest, and holds patents spanning medical devices, immunology and stem cell therapies.
A six-time TED and TEDMED speaker who has delivered keynotes on five continents, Daniel advises biopharma boards and executive teams, health systems and start-ups on AI and digital health strategy. He wrote the lead article for National Geographic’s special issue on the future of medicine, and his work has been featured by CNN and WIRED. Most recently, he joined NewsNation’s The Future is Now town hall on AI, hosted by Chris Cuomo, alongside Neil deGrasse Tyson, Scott Galloway and Bryan Johnson. He is a member of the inaugural class of the Aspen Institute Health Innovators Fellowship and of the Kauffman Fellows Society. An active pilot, he served as an officer and flight surgeon with F-15 and F-16 fighter squadrons in the Massachusetts and California Air National Guard, and was a finalist for NASA astronaut selection.